Roen Rx Review
Best for: patients with insurance seeking brand-name GLP-1 access with compounded fallback
Roen Rx offers compounded semaglutide as well as brand-name Ozempic, Wegovy, Zepbound, and Mounjaro with insurance coordination. LegitScript approved. Insurance-covered brand GLP-1s as low as $25/mo; compounded semaglutide from $151/mo quarterly.
Medium confidence · Last verified 2026-04-10 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Roen Rx is a solid telehealth option with balanced features and pricing.
Score Breakdown
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Compounded Semaglutide (quarterly) | compounded | $151 |
| Brand GLP-1 with insurance | brand | $25 |
✓ Pros
- •Insurance coordination for brand-name GLP-1s — as low as $25/mo
- •Both compounded and brand-name options
- •LegitScript approved with Compounded USA badge
- •Compounded semaglutide from $151/mo quarterly
- •Also offers primary care, mental health, and other specialties
✗ Cons
- •State availability not publicly disclosed
- •Insurance coordination may not work for all plans
- •Broader platform (ED, hair loss, skincare, birth control)
Ready to start with Roen Rx?
Starting at $25/month. See current pricing and start your free consultation.
Sources & methodology
Our Roen Rx review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of April 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
Alternatives to Roen Rx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Ready to start with Roen Rx?
Starting at $25/month. See current pricing and start your free consultation.